Nivolumab-Induced Isolated Adrenal Insufficiency: A Case Report
ABSTRACT: Objective: Novel autoimmune therapies such as nivolumab, an antibody that blocks the programmed death-1 receptor (PD-1), have revolutionized management of patients with cancer. Autoimmune therapies, however, can be associated with immune-related adverse effects. Cases of pituitary and thyr...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2017-01-01
|
| Series: | AACE Clinical Case Reports |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2376060520301838 |